170 related articles for article (PubMed ID: 34399402)
1. Computed tomography-defined low skeletal muscle mass as a prognostic marker for short-term mortality in critically ill patients: A systematic review and meta-analysis.
Meyer HJ; Wienke A; Surov A
Nutrition; 2021; 91-92():111417. PubMed ID: 34399402
[TBL] [Abstract][Full Text] [Related]
2. CT-defined low-skeletal muscle mass as a prognostic marker for survival in prostate cancer: A systematic review and meta-analysis.
Meyer HJ; Wienke A; Surov A
Urol Oncol; 2022 Mar; 40(3):103.e9-103.e16. PubMed ID: 34483042
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography-defined body composition as prognostic markers for unfavourable outcomes and in-hospital mortality in coronavirus disease 2019.
Meyer HJ; Wienke A; Surov A
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):159-168. PubMed ID: 35018725
[TBL] [Abstract][Full Text] [Related]
4. Low skeletal muscle mass defined by thoracic CT as a prognostic marker in acute pulmonary embolism.
Meyer HJ; Benkert F; Bailis N; Lerche M; Denecke T; Surov A
Nutrition; 2022 Jun; 98():111622. PubMed ID: 35436690
[TBL] [Abstract][Full Text] [Related]
5. Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis.
Meyer HJ; Wienke A; Zamsheva M; Surov A
Urol Int; 2023; 107(3):219-229. PubMed ID: 36455534
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and mortality risk of low skeletal muscle mass in critically ill patients: an updated systematic review and meta-analysis.
Yang H; Wan XX; Ma H; Li Z; Weng L; Xia Y; Zhang XM
Front Nutr; 2023; 10():1117558. PubMed ID: 37252244
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis.
Meyer HJ; Strobel A; Wienke A; Surov A
Clin Colorectal Cancer; 2022 Sep; 21(3):e213-e225. PubMed ID: 35792019
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia as a Prognostic Marker for Survival in Gastric Cancer Patients Undergoing Palliative Chemotherapy. A Systematic Review and Meta Analysis.
Meyer HJ; Wienke A; Surov A
Nutr Cancer; 2022; 74(10):3518-3526. PubMed ID: 35603926
[TBL] [Abstract][Full Text] [Related]
9. The use of computed tomography images as a prognostic marker in critically ill cancer patients.
Toledo DO; Carvalho AM; Oliveira AMRR; Toloi JM; Silva AC; Francisco de Mattos Farah J; Prado CM; Silva JM
Clin Nutr ESPEN; 2018 Jun; 25():114-120. PubMed ID: 29779805
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia as a predictor of mortality among the critically ill in an intensive care unit: a systematic review and meta-analysis.
Zhang XM; Chen D; Xie XH; Zhang JE; Zeng Y; Cheng AS
BMC Geriatr; 2021 Jun; 21(1):339. PubMed ID: 34078275
[TBL] [Abstract][Full Text] [Related]
11. CT assessment of preoperative nutritional status in gastric cancer: severe low skeletal muscle mass and obesity-related low skeletal muscle mass are unfavorable factors of postoperative complications.
Fang Z; Du F; Shang L; Liu J; Ren F; Liu Y; Wu H; Liu Y; Li P; Li L
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):317-324. PubMed ID: 33063547
[TBL] [Abstract][Full Text] [Related]
12. CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas.
Surov A; Meyer HJ; Hinnerichs M; Ferraro V; Zeremski V; Mougiakakos D; Saalfeld S; Wienke A; Strobel A; Wolleschak D
Eur Radiol; 2024 Feb; 34(2):790-796. PubMed ID: 37178198
[TBL] [Abstract][Full Text] [Related]
13. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients.
Basile D; Parnofiello A; Vitale MG; Cortiula F; Gerratana L; Fanotto V; Lisanti C; Pelizzari G; Ongaro E; Bartoletti M; Garattini SK; Andreotti VJ; Bacco A; Iacono D; Bonotto M; Casagrande M; Ermacora P; Puglisi F; Pella N; Fasola G; Aprile G; Cardellino GG
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):368-377. PubMed ID: 30719874
[TBL] [Abstract][Full Text] [Related]
14. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
Nishimura JM; Ansari AZ; D'Souza DM; Moffatt-Bruce SD; Merritt RE; Kneuertz PJ
Ann Thorac Surg; 2019 Nov; 108(5):1555-1564. PubMed ID: 31228408
[TBL] [Abstract][Full Text] [Related]
15. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.
Surov A; Pech M; Gessner D; Mikusko M; Fischer T; Alter M; Wienke A
Clin Nutr; 2021 Oct; 40(10):5298-5310. PubMed ID: 34536638
[TBL] [Abstract][Full Text] [Related]
16. The impact of computed tomography-assessed sarcopenia on outcomes for trauma patients - a systematic review and meta-analysis.
Xia W; Barazanchi AWH; MacFater WS; Hill AG
Injury; 2019 Sep; 50(9):1565-1576. PubMed ID: 31280971
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis.
Tranoulis A; Kwong FLA; Lakhiani A; Georgiou D; Yap J; Balega J
Eur J Surg Oncol; 2022 Jul; 48(7):1441-1454. PubMed ID: 35260290
[TBL] [Abstract][Full Text] [Related]
18. Identifying critically ill patients with low muscle mass: Agreement between bioelectrical impedance analysis and computed tomography.
Looijaard WGPM; Stapel SN; Dekker IM; Rusticus H; Remmelzwaal S; Girbes ARJ; Weijs PJM; Oudemans-van Straaten HM
Clin Nutr; 2020 Jun; 39(6):1809-1817. PubMed ID: 31492456
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis.
March C; Omari J; Thormann M; Pech M; Wienke A; Surov A
Clin Nutr ESPEN; 2022 Jun; 49():103-113. PubMed ID: 35623801
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
